Augtyro (repotrectinib)

In Stock

Augtyro (repotrectinib)

By
CHEMMEDIX

Original price was: $6,000.00.Current price is: $4,600.00.

Request this medicine

Patients helped

Over 1.2 million patients reached
More than 11,000 patients helped
100% successful deliveries to 88 countries

We can help with your prescription

We are experts in import regulations.

Category:

Description

We can help with your prescription.
You can access this medicine even if it’s not approved in your country.

Augtyro (repotrectinib) is a prescription medicine for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer 1.

Augtyro (repotrectinib) is approved by the FDA in the USA 2.

 

Disease Indications

Lung Cancer

Manufacturer

Bristol-Myers Squibb

Usage

Oral

Medicine approved by

Food and Drug Administration (FDA)

Reviews

There are no reviews yet.

Be the first to review “Augtyro (repotrectinib)”

Your email address will not be published. Required fields are marked *

Use the form to Request for this Medicine

Please enable JavaScript in your browser to complete this form.
Name
Are you a...